Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

India · Delayed Price · Currency is INR

152.50

+0.83 (0.55%)

Sep 10, 2026, 3:29 PM IST

Market Cap	2.90B -9.3%
Revenue (ttm)	4.90B +21.0%
Net Income	456.11M +7.3%
EPS	22.99 +2.9%
Shares Out	19.00M
PE Ratio	6.63
Forward PE	n/a
Dividend	2.00 (1.32%)
Ex-Dividend Date	Sep 11, 2026

Volume	2,278
Open	153.00
Previous Close	151.67
Day's Range	151.01 - 153.45
52-Week Range	126.15 - 204.00
Beta	0.84
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jowar; and seeds for vegetables comprising chilli, okra, tomato, bitter gourd, and cucumber. It also provides crop protection supplements under the Win-ch... [Read more]

Industry Agricultural Inputs

Sector Materials

Founded 1979

Employees 451

Stock Exchange National Stock Exchange of India

Ticker Symbol NATHBIOGEN

Full Company Profile

Financial Performance

In fiscal year 2026, Nath Bio-Genes (India)'s revenue was 4.45 billion, an increase of 21.95% compared to the previous year's 3.65 billion. Earnings were 416.30 million, an increase of 7.85%.

Financial Statements